Home Stocks ASX NEU:NEUREN PHARMACEUTICALS LIMITED
Listed Company

Neuren Pharmaceuticals Limited (ASX NEU)

Followers 52
Exchange ASX
Sector Health Care
Industry Pharmaceuticals, Biotechnology & Life Sciences

popular wires mentioning NEU

The Match Out: ASX rallies ahead of US Rates decision, Energy the standout

The Match Out: ASX rallies ahead of US Rates decision, Energy the standout

The daily Match Out for Wednesday 22 March with Market Matters' James Gerrish.

Market Matters
The Match Out: Energy hit on growth concerns, ASX at 2-month lows.

The Match Out: Energy hit on growth concerns, ASX at 2-month lows.

The daily Match Out for Tuesday 14 March with Market Matters' James Gerrish.

Market Matters
16 new stocks added to the ASX 300 - only 7 make a profit

16 new stocks added to the ASX 300 - only 7 make a profit

In March, QVG Capital presented a webinar which talked about, among other things, the proportion of unprofitable companies entering the ASX300. At the time we noted just 4 of the 14 entries were profitable. Given, the next batch of companies entered the S&P/ASX300 last Friday we felt it was...

QVG Capital
The Match Out: 9-month high for the ASX, 5 consecutive positive sessions, Sandfire announced 2Q update

The Match Out: 9-month high for the ASX, 5 consecutive positive sessions, Sandfire announced 2Q update

It was a case of rinse & repeat for the ASX today with early sold-off then seeing support kicking in before midday to take the index to a new 9-month high. Despite the strength in the index, the banks failed to join the rally, certainly surprising to see such a...

Market Matters

Watch

The Match Out: ASX rallies ahead of US Rates decision, Energy the standout

Market Matters

Latest on NEUREN PHARMACEUTICALS LIMITED

Daily Report

The Match Out: ASX rallies ahead of US Rates decision, Energy the standout

The daily Match Out for Wednesday 22 March with Market Matters' James Gerrish.
+4
James Gerrish
Market Matters
Daily Report

The Match Out: Energy hit on growth concerns, ASX at 2-month lows.

The daily Match Out for Tuesday 14 March with Market Matters' James Gerrish.
+3
James Gerrish
Market Matters
Daily Report

The Match Out: 9-month high for the ASX, 5 consecutive positive sessions, Sandfire announced 2Q update

It was a case of rinse & repeat for the ASX today with early sold-off then seeing support kicking in before midday to take the index to a new 9-month high. Despite the...
ABC
ANN
+25
James Gerrish
Market Matters
Equities

Calcutta 2023: Australia's brightest investors name 17 top stocks for the year ahead

After two years of events forced online by what now feels like a distant memory of a pandemic, hundreds of the Australian funds management industry's finest flocked...
360
+17
Ally Selby
Livewire Markets
Equities

16 new stocks added to the ASX 300 - only 7 make a profit

In March, QVG Capital presented a webinar which talked about, among other things, the proportion of unprofitable companies entering the ASX300. At the time we noted...
+13
Chris Prunty
QVG Capital

Covering Neuren Pharmaceuticals Limited

Bell Potter
Stockbroker
James Gerrish
Market Matters
Chris Prunty
QVG Capital
Ben Williamson
Fresh Equities
Ally Selby
Livewire Markets
Hashan De Silva
Karst Peak Capital

Neuren Pharmaceuticals Limited (ASX:NEU) is an Australian publicly listed company that trades on the Australian Stock Exchange. The company's stock code is NEU. Livewire Markets has 8 experts who have published 10 articles that have featured Neuren Pharmaceuticals Limited. You can view all those wires here. The last time time NEU was featured was on the 22 March 2023 by James Gerrish in the wire “The Match Out: ASX rallies ahead of US Rates decision, Energy the standout”.